Big gains for the e-commerce and online grocer this morning after they announced a partnership deal with Asda. The move will see Ocado’s platform being used to upgrade and replace the existing Asda online infrastructure, with roll out expected in 2027. Today’s note explicitly adds that there will be no monetary impact in the current financial year but the Ocado share price was trading up more than 11% shortly after the open.
Small cap diagnostics and precision oncology provider CelLBxHealth issued a note this morning stating that they had signed a Master Services Agreement with AstraZeneca. Details of the deal beyond it enabling AstraZeneca to access CelLBxHealth capabilities across their development pipeline are thin on the ground, but clearly this presents some significant commercial opportunities. The CelLBxHealth share price was 37% higher in early trade.
The AIM listed hydrogen electrolyser company request its shares be suspended this morning following a cash squeeze and a major incident in a factory acceptance test procedure. Funding conversations had been advancing but these have now been called into question and with significant damage having been sustained on the electrolyser, completion of the tests will be materially delayed.
Most read news on Investegate this morning
Time Out Market Vancouver Opens - - Time Out Group (TMO)
Grant of awards under Long Term Incentive Plan - - Hvivo (HVO)
Circular Posted & Notice of Warrantholder Meetings - - Sundae Bar Plc (SBAR)
